• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脲基的Apcin类似物作为针对癌症的Cdc20特异性抑制剂的发现。

Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer.

作者信息

He Yiqin, Le Xiangyang, Hu Gaoyun, Li Qianbin, Chen Zhuo

机构信息

Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.

Hunan Key Laboratory of Organ Fibrosis, Changsha 410013, China.

出版信息

Pharmaceuticals (Basel). 2023 Feb 15;16(2):304. doi: 10.3390/ph16020304.

DOI:10.3390/ph16020304
PMID:37259447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9964651/
Abstract

Cdc20 is a promising drug target that plays an important role in the mid-anaphase process of cellular mitosis, and Apcin is the only reported core structure of the Cdc20-specific inhibitor. Some potent Apcin derivatives were obtained in our previous research, and a structure-activity relationship was determined. In this study, we designed and synthesized a series of ureido-based Apcin derivatives. The proliferation-inhibition experiments on four cancer-cell lines showed that ureido skeleton could promote the anti-proliferation activity of purine-substituted compounds, whereas the ureido analogues with pyrimidine substitutes showed no significant improvement in the inhibitory effect compared with the original ones. Further tests confirmed that ureido-based compounds can enhance the binding affinity to Cdc20 by increasing the levels of Cdc20 downstream proteins. Compound revealed a remarkably antitumor activity pattern against Hela (IC = 0.06 ± 0.02 μM) and potent binding affinity to Cdc20. Moreover, compound induced caspase-dependent apoptosis and cell-cycle arrest at the G2/M phase, and compound induced caspase-dependent apoptosis and promoted microtubule polymerization. Finally, a molecular-docking simulation was performed for compounds and to predict the potential ligand-protein interactions with the active sites of the Cdc20 proteins.

摘要

Cdc20是一个很有前景的药物靶点,在细胞有丝分裂的中后期过程中发挥重要作用,而Apcin是唯一报道的Cdc20特异性抑制剂的核心结构。在我们之前的研究中获得了一些有效的Apcin衍生物,并确定了构效关系。在本研究中,我们设计并合成了一系列基于脲基的Apcin衍生物。对四种癌细胞系的增殖抑制实验表明,脲基骨架可促进嘌呤取代化合物的抗增殖活性,而嘧啶取代的脲基类似物与原始化合物相比,其抑制效果没有显著改善。进一步的测试证实,基于脲基的化合物可通过增加Cdc20下游蛋白的水平来增强与Cdc20的结合亲和力。化合物 对Hela显示出显著的抗肿瘤活性模式(IC = 0.06 ± 0.02 μM)以及与Cdc20的强结合亲和力。此外,化合物 诱导半胱天冬酶依赖性凋亡并使细胞周期停滞在G2/M期,化合物 诱导半胱天冬酶依赖性凋亡并促进微管聚合。最后,对化合物 和 进行了分子对接模拟,以预测与Cdc20蛋白活性位点的潜在配体-蛋白质相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/81a1b068e2ce/pharmaceuticals-16-00304-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/2bddf531ddeb/pharmaceuticals-16-00304-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/f854ee994595/pharmaceuticals-16-00304-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/7ddb9be73e8b/pharmaceuticals-16-00304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/fb05b5da3c74/pharmaceuticals-16-00304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/b93c6c9f8a88/pharmaceuticals-16-00304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/985fffd3af4b/pharmaceuticals-16-00304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/0a761b271c6e/pharmaceuticals-16-00304-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/12c2ee23d620/pharmaceuticals-16-00304-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/40a14eebf72f/pharmaceuticals-16-00304-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/81a1b068e2ce/pharmaceuticals-16-00304-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/2bddf531ddeb/pharmaceuticals-16-00304-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/f854ee994595/pharmaceuticals-16-00304-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/7ddb9be73e8b/pharmaceuticals-16-00304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/fb05b5da3c74/pharmaceuticals-16-00304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/b93c6c9f8a88/pharmaceuticals-16-00304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/985fffd3af4b/pharmaceuticals-16-00304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/0a761b271c6e/pharmaceuticals-16-00304-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/12c2ee23d620/pharmaceuticals-16-00304-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/40a14eebf72f/pharmaceuticals-16-00304-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2ef/9964651/81a1b068e2ce/pharmaceuticals-16-00304-g008.jpg

相似文献

1
Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer.基于脲基的Apcin类似物作为针对癌症的Cdc20特异性抑制剂的发现。
Pharmaceuticals (Basel). 2023 Feb 15;16(2):304. doi: 10.3390/ph16020304.
2
Antitumor Effect of Apcin on Endometrial Carcinoma via p21-Mediated Cell Cycle Arrest and Apoptosis.Apcin 通过 p21 介导的细胞周期阻滞和细胞凋亡对子宫内膜癌的抗肿瘤作用。
Curr Med Sci. 2024 Jun;44(3):623-632. doi: 10.1007/s11596-024-2877-z. Epub 2024 Jun 10.
3
Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin.通过对 Apcin 的结构修饰发现一种双重微管聚合和细胞分裂周期 20 同源物抑制剂。
J Med Chem. 2020 May 14;63(9):4685-4700. doi: 10.1021/acs.jmedchem.9b02097. Epub 2020 Apr 27.
4
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors.基于Apcin的细胞周期蛋白依赖性激酶20(CDC20)抑制剂的设计、合成及生物学评价
ACS Med Chem Lett. 2022 Jan 18;13(2):188-195. doi: 10.1021/acsmedchemlett.1c00544. eCollection 2022 Feb 10.
5
Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancer.设计、合成和生物评价 CDC20 抑制剂用于治疗三阴性乳腺癌。
Eur J Med Chem. 2024 Mar 15;268:116204. doi: 10.1016/j.ejmech.2024.116204. Epub 2024 Feb 8.
6
Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells.Cdc20 抑制剂 apcin 抑制骨肉瘤细胞的生长和侵袭。
Oncol Rep. 2018 Aug;40(2):841-848. doi: 10.3892/or.2018.6467. Epub 2018 May 30.
7
Paradoxical mitotic exit induced by a small molecule inhibitor of APC/C.小分子 APC/C 抑制剂诱导的矛盾有丝分裂退出
Nat Chem Biol. 2020 May;16(5):546-555. doi: 10.1038/s41589-020-0495-z. Epub 2020 Mar 9.
8
p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma.p53直接下调CDC20的表达,从而在套细胞淋巴瘤中发挥抗肿瘤活性。
Exp Hematol Oncol. 2023 Mar 7;12(1):28. doi: 10.1186/s40164-023-00381-7.
9
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.合成芳基噻唑连接 2H-吲哚-2-酮衍生物作为 VEGFR-2 激酶抑制剂的分子对接和体外抗癌筛选。
Anticancer Agents Med Chem. 2022;22(11):2166-2180. doi: 10.2174/1871520621666211118102139.
10
Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.抑制后期促进复合体/细胞周期体可诱导多发性骨髓瘤细胞发生中期阻滞和细胞死亡。
Oncotarget. 2016 Jan 26;7(4):4062-76. doi: 10.18632/oncotarget.6768.

本文引用的文献

1
Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin.通过对 Apcin 的结构修饰发现一种双重微管聚合和细胞分裂周期 20 同源物抑制剂。
J Med Chem. 2020 May 14;63(9):4685-4700. doi: 10.1021/acs.jmedchem.9b02097. Epub 2020 Apr 27.
2
APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.APC/C 泛素连接酶:在肿瘤发生中的功能和机制。
Semin Cancer Biol. 2020 Dec;67(Pt 2):80-91. doi: 10.1016/j.semcancer.2020.03.001. Epub 2020 Mar 9.
3
Paradoxical mitotic exit induced by a small molecule inhibitor of APC/C.
小分子 APC/C 抑制剂诱导的矛盾有丝分裂退出
Nat Chem Biol. 2020 May;16(5):546-555. doi: 10.1038/s41589-020-0495-z. Epub 2020 Mar 9.
4
Improving scoring-docking-screening powers of protein-ligand scoring functions using random forest.利用随机森林提高蛋白质-配体评分函数的评分-对接-筛选能力
J Comput Chem. 2017 Jan 30;38(3):169-177. doi: 10.1002/jcc.24667. Epub 2016 Nov 17.
5
Molecular basis of APC/C regulation by the spindle assembly checkpoint.纺锤体组装检查点对后期促进复合物/细胞周期体(APC/C)调控的分子基础
Nature. 2016 Aug 25;536(7617):431-436. doi: 10.1038/nature19083. Epub 2016 Aug 10.
6
Dual RING E3 Architectures Regulate Multiubiquitination and Ubiquitin Chain Elongation by APC/C.双环E3架构通过后期促进复合物/细胞周期体(APC/C)调控多聚泛素化和泛素链延伸。
Cell. 2016 Jun 2;165(6):1440-1453. doi: 10.1016/j.cell.2016.05.037.
7
The Bub1-Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation.Bub1与Plk1激酶复合物通过Cdc20磷酸化促进纺锤体检查点信号传导。
Nat Commun. 2016 Feb 25;7:10818. doi: 10.1038/ncomms10818.
8
Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.通过两种后期促进复合物/细胞周期体(APC/C)化学抑制剂对有丝分裂退出的协同阻断
Nature. 2014 Oct 30;514(7524):646-9. doi: 10.1038/nature13660. Epub 2014 Aug 24.
9
APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.APC(Cdc20) 通过靶向 Bim 进行泛素化和降解来抑制细胞凋亡。
Dev Cell. 2014 May 27;29(4):377-91. doi: 10.1016/j.devcel.2014.04.022.
10
Cdc20 and securin overexpression predict short-term breast cancer survival.Cdc20 和 securin 过表达预测乳腺癌短期生存。
Br J Cancer. 2014 Jun 10;110(12):2905-13. doi: 10.1038/bjc.2014.252. Epub 2014 May 22.